Ignite Creation Date:
2025-12-26 @ 5:21 PM
Ignite Modification Date:
2026-02-06 @ 2:28 AM
Study NCT ID:
NCT06580106
Status:
RECRUITING
Last Update Posted:
2025-07-24
First Post:
2024-08-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
Sponsor:
Organization:
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: